The $27 Billion Market Most Investors Never Heard Of-- And The Hottest Stocks In The Space
ACCESSWIRE - Sun May 17, 2:47PM CDT
ONTARIO, CA / ACCESSWIRE / May 17, 2015 / The Wealthy Biotech Trader, an investment newsletter focused on showing everyday Investors new opportunities in little known, rapidly growing Biotech stocks making news and subsequent market moves would like to introduce its #1 pick for Summer.
VCYT: 9.27 (+0.70), APDN: 2.53 (-0.06), ERB: 3.05 (-0.01)
The $30 Billion Market Most Investors Never Heard Of
M2 - Wed May 13, 11:29AM CDT
Molecular diagnostics and testing equipment is a growing sector within medical equipment that has and should potentially continue to outperform the market. There are different technologies and companies that stand to benefit from strong fundamentals. They have higher than average long-term growth outlooks and could experience a rapid increase in sales over the next few years. These stocks with strong market positions or leading technology will benefit. We expect stocks like PositiveID (OTC: PSID), Sequenom (NASDAQ: SQNM), Bio-Rad Laboratories (NYSE: BIO), and Cepheid (NASDAQ: CPHD) to outperform potentially. In particular, PositiveID is undervalued according to some analysts and trades at discounted valuations versus their peers due to the lower visibility of the OTC exchange compared to national exchanges like the Nasdaq--but that can change rather quickly.
SQNM: 3.69 (-0.12), BIO: 146.16 (+2.03), CPHD: 57.71 (-0.39)
PositiveID Corporation to Present at the 2015 Marcum MicroCap Conference
GlobeNewswire - Wed May 13, 7:30AM CDT
PositiveID Corporation ("PositiveID" or "Company"
PositiveID Successfully Expands Testing of Firefly Dx PCR Chip to Food Safety Market, Detecting E. coli in Less Than 20 Minutes
GlobeNewswire - Wed May 06, 7:30AM CDT
PositiveID Corporation ("PositiveID" or "Company"
Global Blood Glucose Meters Pipeline Review 2015
M2 - Tue Apr 28, 4:02AM CDT
Research and Markets (http://www.researchandmarkets.com/research/vhqtk3/blood_glucose) has announced the addition of the "Blood Glucose Meters - Pipeline Review, 2015" report to their offering. The report provides comprehensive information on the pipeline products with comparative analysis of the products at various stages of development. The report reviews major players involved in the pipeline product development. It also provides information about clinical trials in progress, which includes trial phase, trial status, trial start and end dates, and, the number of trials for the key blood glucose meters pipeline products. Scope: - Extensive coverage of the Blood Glucose Meters products under development - The report reviews details of major pipeline products which includes, product description, licensing and collaboration details and other developmental activities - The report reviews the major players involved in the development of Blood Glucose Meters and list all their pipeline projects - The coverage of pipeline products based on various stages of development ranging from Early Development to Approved / Issued stage - The report provides key clinical trial data of ongoing trials specific to pipeline products - Recent developments in the segment / industry The report enables you to: - Formulate significant competitor information, analysis, and insights to improve R&D strategies - Identify emerging players with potentially strong product portfolio and create effective counter-strategies to gain competitive advantage - Identify and understand important and diverse types of Blood Glucose Meters under development - Develop market-entry and market expansion strategies - Plan mergers and acquisitions effectively by identifying major players with the most promising pipeline - In-depth analysis of the product's current stage of development, territory and estimated launch date Companies Featured - Partial List - C8 MediSensors, Inc. - GlucoSet AS - Glucovation, Inc. - GluMetrics, Inc. - GluSense Ltd. - GlySens Incorporated - GlySure Ltd - Grove Instruments Inc. - Hygiena, LLC - Hypo-Safe A/S - Mendor Oy - MicroCHIPS, Inc. - mobiLIFE - Nagasaki University - Nemaura Medical Inc - Newton Photonics Inc - Northwestern University - NovioSense B.V. - Optiscan Biomedical Corporation - Pepex Biomedical, Inc. - Pignolo SpA - PositiveID Corporation - Quick, LLC - Senseonics, Incorporated - Sentec Ag - Senzime AB - Socrates Health Solutions, Inc. - University of Western Ontario - Vytrace, Inc. - Xhale, Inc. For more information visit http://www.researchandmarkets.com/research/vh...od_glucose
Small Cap IR Issues Analyst Coverage of PositiveID Corporation
PR Newswire - Fri Apr 24, 6:00AM CDT
Small Cap IR issues analyst report. PositiveID Corporation (OTCQB: PSID) is an emerging growth company and developer of biological detection and diagnostic systems for America's homeland defense and the global healthcare market. The company specializes in developing microfluidic systems for the automated preparation of and performance of biological assays in order to be able to detect biological threats and outbreaks, whether airborne, in a healthcare setting, or at the point of need.
PositiveID Corporation Discusses Firefly Dx Development Progress in New Interview With SmallCapVoice.com
GlobeNewswire - Thu Apr 16, 7:05AM CDT
SmallCapVoice.com, Inc. today announced it conducted a new audio interview with PositiveID Corporation ("PositiveID" or the "Company"
PositiveID Announces First Quarter Highlights
GlobeNewswire - Wed Apr 15, 7:30AM CDT
PositiveID Corporation ("PositiveID" or "Company"
PositiveID Successfully Detects Multiple Organisms From a Single Assay on Its Firefly Dx PCR Chip
GlobeNewswire - Thu Apr 02, 7:30AM CDT
PositiveID Corporation ("PositiveID" or "Company"
Ticker Research Issues Company Update On PositiveID Corporation
ACCESSWIRE - Tue Mar 24, 3:30PM CDT
ROCHESTER, NY / ACCESSWIRE / March 24, 2015 / Ticker Research, a market research firm focused on the micro cap and small cap sectors, has issued a company update on Positive ID Corporation (PSID) an emerging growth company and developer of biological detection systems for America's homeland defense industry as well as rapid biological testing.
Penny Stocks Alerts for PositiveID, GT Advanced, Tanzanian Royalty Exploration, Sino Agro Food, Aoxing Pharmaceutical, and MusclePharm
PR Newswire - Mon Mar 23, 7:45AM CDT
Pennystocksinsiders.com (PSI) released FREE insider trading reports for US market investors to track the following active stocks and penny stocks: PositiveID (OTCMKTS: PSID), GT Advanced (OTCMKTS: GTATQ), Tanzanian Royalty Exploration (NYSEMKT: TRX), Sino Agro Food (OTCBB: SIAF), Aoxing Pharmaceutical (NYSEMKT: AXN), and MusclePharm (OTCMKTS: MSLP).
AXN: 1.66 (-0.06), TRX: 0.34 (-0.01)
Biotechnology And The Road To Innovation: What Companies Are Pushing New Innovation In Today's Market?
ACCESSWIRE - Thu Mar 19, 8:15AM CDT
CORAL GABLES, FL / ACCESSWIRE / March 19, 2015 / Globally, the market for biotechnology has been growing at a rate of over 10% annually according to a report from IBISWorld. Annual revenue is on the cusp of breaking $290 Billion and has many sub sectors contributing to its further expansion. Industry firms have thrived as technological advances have facilitated new discoveries and ignited higher demand from firms in the pharmaceuticals and agricultural sectors. According to the report, industry growth is forecast to continue "skyrocketing in the next five-year period" where investment in biotechnology from around the world increases, particularly from emerging economies.
PositiveID Corporation Files Additional U.S. Patent for Its Firefly Dx Real-Time PCR System
GlobeNewswire - Wed Mar 18, 7:30AM CDT
PositiveID Corporation ("PositiveID" or "Company"
PositiveID Announces First Firefly Dx Testing and Delivery of Positive PCR Results Within 20 Minutes
GlobeNewswire - Thu Mar 12, 7:30AM CDT
PositiveID Corporation ("PositiveID" or "Company"
PositiveID Poised To Carve Out Its Share of the $27.4 Billion Global Polymerase Chain Reaction (PCR) Market in 2015: Analyst Report Issued by Small Cap IR
PR Newswire - Thu Mar 12, 6:00AM CDT
PositiveID Corporation (OTCQB: PSID) coordinates with America's homeland defense private/public sectors to develop and produce cutting edge technologies. The Company has been working on the development of microfluidic systems with the ability to detect biological threats remotely, and analyze medical samples onsite.
Tech Takes Center Stage As New Innovation Blazes New Trails
ACCESSWIRE - Thu Feb 19, 8:20AM CST
CORAL GABLES, FL / ACCESSWIRE / February 19, 2015 / According to CEIMarket, the technology sector recorded an above average Revenue growth of 14.69 % year over year in Q4, 2014. Furthermore, sequentially revenues for Technology Sector grew by 24.57% with computer hardware, communications equipment, scientific & tech instruments, and computer services shining as sector standouts that are leading this growth. As new industries continue to develop and old markets become rejuvenated by fresh ideas, the technology space has been one to watch heading into the new year.
SeeThruEquity Issues Update Note on PositiveID Corporation
ACCESSWIRE - Tue Feb 17, 8:02AM CST
NEW YORK, NY / ACCESSWIRE / February 17, 2015 / SeeThruEquity, a leading independent equity research and corporate access firm focused on smallcap and microcap public companies, today announced that it has issued a special update note on Positive ID Corporation (OTCQB
PositiveID Corporation Achieves Firefly Dx Development Milestone With Completion of Breadboard PCR
GlobeNewswire - Thu Feb 12, 7:30AM CST
PositiveID Corporation ("PositiveID" or "Company"
PositiveID Corporation Issues Revenue Guidance of $3-6 Million for 2015
GlobeNewswire - Thu Feb 05, 7:30AM CST
PositiveID Corporation ("PositiveID" or "Company"